OakChart

AN2 Therapeutics Inc

ANTXHealthcare·Biotechnology·USA·Micro·NASD·Nov 11 • 3:59 PM ET

4.46+0.13 (3.00%)
2026-11-12 00:28 CET
Market cap
163.40 USD m
Revenue, TTM
0.00 USD m
Net income, TTM
-34.88 USD m
Free cash flow, TTM
-30.41 USD m
EPS diluted, TTM
-0.94
P/E
-
Compare

Price

ANTX against its 20, 50 and 200-day averages
2050200earnings
2.004.006.001.8M3.6MVolumeMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26ANTXclose 4.4620-day 3.9750-day 4.67200-day 4.194.4652w high

38.0% under the 52-week high of 7.19 on 12 Aug 2026. 52-week low 1.00 on 5 Jan 2026. Last 15 sessions, 41.2% high to low

Volume 0.73× normal · the line is the 50-bar volume average

Profile

ANTX
52-week range, 56% of the way up
1.007.19

AN2 Therapeutics, Inc. operates as a global health biopharmaceutical company. The firm focuses on modern biomedical and drug development to provide transformational medicines for patients suffering from infectious diseases. The company was founded by Eric Easom, George Harrison Talbot, Joseph S. Zakrzewski and Michael R.K. Alley in 2017 and is headquartered in Menlo Park, CA.

IndexRUT
Employees21
IPOMar 25, 2022
Beta-0.92
ATR, 14d0.37
Rel volume0.73
Short float8.63%
Insider own25.03%
Inst own66.95%

Snapshot

6 groups

Valuation

IndexRUT
Market Cap169.23M
Enterprise Value104.83M
Income-34.88M
Sales0.00M
Book/sh1.99
Cash/sh1.70
Dividend Est.-
Dividend TTM-
Dividend Ex-Date-
Dividend Gr. 3/5Y- -
Payout-
Employees21
IPOMar 25, 2022

Ratios

P/E-
Forward P/E-
PEG-
P/S-
P/B2.24
P/C2.63
P/FCF-
EV/EBITDA-
EV/Sales-
Quick Ratio10.48
Current Ratio10.48
Debt/Eq0.00
LT Debt/Eq0.00
Option/ShortYes / Yes

Earnings

EPS (ttm)-0.94
EPS next Y-0.77
EPS next Q-0.23
EPS this Y25.00%
EPS next Y12.07%
EPS next 5Y12.20%
EPS past 3/5Y19.17% -8.39%
Sales past 3/5Y- -
EPS Y/Y TTM17.03%
Sales Y/Y TTM-
EPS Q/Q44.12%
Sales Q/Q-
EarningsNov 09 BMO
EPS/Sales Surpr.15.00% -

Ownership

Insider Own25.03%
Insider Trans-0.63%
Inst Own66.95%
Inst Trans5.53%
ROA-46.76%
ROE-51.34%
ROIC-46.19%
Gross Margin-
Oper. Margin-
Profit Margin-
SMA2012.26%
SMA50-4.44%
SMA2006.44%
Trades-

Technical

Shs Outstand37.89M
Shs Float28.29M
Short Float8.63%
Short Ratio9.07
Short Interest2.44M
52W High7.19 -37.97%
52W Low1.00 346.00%
Volatility8.11% 9.23%
ATR (14)0.37
RSI (14)54.20
Beta-0.92
Rel Volume0.73
Avg Volume268.95K
Volume197,638

Performance

Perf Week4.94%
Perf Month23.89%
Perf Quarter-25.42%
Perf Half Y3.48%
Perf YTD291.23%
Perf Year271.67%
Perf 3Y-68.83%
Perf 5Y-
Perf 10Y-
Recom1.00
Target Price9.00
Prev Close4.33
Price4.46
Change %3.00%

Analyst ratings

latest 10 of 11
DateActionAnalystRating changeTargetImplied
May 14, 2026UpgradeLLeerink PartnersMarket Perform → Outperform$9+101.8%
Aug 09, 2024DowngradeLLeerink PartnersOutperform → Market Perform$5 → $1-77.6%
Aug 09, 2024DowngradeEEvercore ISIIn-line → Underperform
Jul 03, 2024UpgradeLLeerink PartnersMarket Perform → Outperform$5+12.1%
Apr 02, 2024UpgradeJJMP SecuritiesMkt Perform → Mkt Outperform$6+34.5%
Feb 13, 2024DowngradeLLeerink PartnersOutperform → Market Perform$23 → $7+57.0%
Feb 12, 2024DowngradeOOppenheimerOutperform → Perform
Feb 12, 2024DowngradeJJMP SecuritiesMkt Outperform → Mkt Perform
Feb 12, 2024DowngradeEEvercore ISIOutperform → In-line$25 → $7+57.0%
Jan 04, 2024InitiatedJJMP SecuritiesMkt Outperform$30+572.6%

Peers

Mkt cap
TickerCompanyMkt cap
INSMInsmed Inc26.49B
SPROSpero Therapeutics Inc59.40M
ARMPArmata Pharmaceuticals Inc144.64M
AVIRAtea Pharmaceuticals Inc338.89M
ENTAEnanta Pharmaceuticals Inc337.86M
COCPCocrystal Pharma Inc19.65M
ACXPAcurx Pharmaceuticals Inc5.72M
CRMDCorMedix Inc413.10M
SNGXSoligenix Inc7.51M
TRAWTraws Pharma Inc3.84M

Insider trading

latest 14 of 19
InsiderRelationshipDateTransactionCostSharesValueTotal heldForm
Eizen Joshua MSee RemarksNov 05 '26Sale4.222,82611,926207,546Nov 06 06:20 PM
Readnour Robin ShaneDirectorSep 09 '26Sale6.021,1086,675557,467Sep 11 07:45 PM
Readnour Robin ShaneDirectorSep 08 '26Sale6.0210,01960,297557,990Sep 08 07:42 PM
Readnour Robin ShaneDirectorSep 03 '26Sale6.076,10037,026562,715Sep 08 07:42 PM
Williams Sarah JoannePrincipal Accounting OfficerSep 01 '26Sale5.532721,50466,311Sep 04 04:25 PM
FitzPatrick Margaret MDirectorSep 01 '26Buy5.532,09811,60210,708Sep 02 06:43 PM
Readnour Robin ShaneDirectorAug 17 '26Sale6.0135,402212,702565,592Aug 19 05:58 PM
Readnour Robin ShaneDirectorAug 17 '26Proposed Sale6.011,012,0006,080,268Aug 17 04:24 PM
Eizen Joshua MSee RemarksJul 08 '26Sale4.175,94524,803206,554Jul 10 06:15 PM
Williams Sarah JoannePrincipal Accounting OfficerMay 29 '26Sale4.432651,17466,583Jun 02 04:31 PM
Williams Sarah JoannePrincipal Accounting OfficerMar 03 '26Sale1.0632734766,848Mar 05 06:55 PM
Day LucyChief Financial OfficerJan 06 '26Sale1.015,5125,57875,363Jan 07 08:15 PM
Day LucyChief Financial OfficerJan 05 '26Sale1.003,2953,30580,875Jan 07 08:15 PM
Prior Stephen DavidChief Strategy OfficerJan 05 '26Sale1.003,6043,61561,944Jan 07 08:15 PM

Held by

AUM
TickerCompanyAUM
VTIVanguard Morningstar Total Stock Market ETFAUM: 687.42B
IWMiShares Russell 2000 Index FundAUM: 77.38B
VXFVanguard Extended Market Index ETFAUM: 30.47B
IWNiShares Russell 2000 Value ETFAUM: 14.10B
VTWOVanguard Russell 2000 Index ETFAUM: 16.75B
IWCiShares Micro-Cap ETFAUM: 1.22B
BUSMEA Bridgeway Ultra-Small Company Market ETFAUM: 111.21M
GSSCGoldman Sachs ActiveBeta U.S. Small Cap Equity ETFAUM: 1.06B
DFASU.S. Small Cap Portfolio-ETF Class SharesAUM: 15.51B
AVSCAvantis U.S Small Cap Equity ETFAUM: 3.23B

News

latest 14 of 200

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2026Q32026-11-09-0.170-0.200-0.2000.000.002
2026Q22026-08-11-0.180-0.240-0.1830.000.002
2026Q12026-05-11-0.290--0.2940.00--
2025Q42026-03-17-0.290-0.240-0.2870.000.001
2025Q32025-11-12-0.310-0.220-0.3090.000.002
2025Q22025-08-12-0.210-0.335-0.2140.000.002
2025Q12025-05-13-0.350-0.265-0.3540.000.004
2024Q42025-03-25-0.250-0.270-0.2520.000.005
2024Q32024-11-13-0.430-0.450-0.4270.000.004
2024Q22024-08-13-0.480-0.606-0.4840.000.005
2024Q12024-05-14-0.560-0.620-0.5580.000.004
2023Q42024-03-28-0.570-0.736-0.5680.000.005
2023Q32023-11-09-0.650-0.648-0.6520.000.004
2023Q22023-08-10-0.810-0.853-0.8110.000.004
2023Q12023-05-11-0.790-0.658-0.7900.000.004
2022Q42023-03-29-0.610-0.633-0.6100.000.004

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2021FY-14.610--1.4990.00-
2022FY-2.790-3.138-2.2050.000.00
2023FY-2.740-2.976-2.7430.000.00
2024FY-1.720-1.724-1.7210.000.00
2025FY-1.160-1.120-2.7400.000.00
2026FY--0.870--0.00
2027FY--0.765--0.00
2028FY--0.785--0.00
2029FY--0.770--0.00
2030FY--0.850--0.00

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2026Q4S2026-11-092000.000.000.00
2026Q4S2026-08-122000.000.000.00
2026Q4S2026-07-172000.000.000.00
2026Q4S2026-05-131000.000.000.00
2026Q4S2025-11-131000.000.000.00
2026Q4S2025-11-111000.000.000.00
2026Q4S2025-11-101000.000.000.00
2026Q4S2025-11-091000.000.000.00
2026Q4R2026-11-09100-0.25-0.25-0.25
2026Q4R2026-10-30100-0.25-0.25-0.25
2026Q4E2026-11-10210-0.23-0.26-0.19
2026Q4E2026-11-09200-0.24-0.26-0.21
2026Q4E2026-10-27200-0.24-0.26-0.21
2026Q4E2026-10-26210-0.24-0.26-0.21

Estimate history

EPS, annual-0.306-0.778-1.499-2.205-2.743-1.721-1.164-0.9368
Period2019202020212022202320242025TTM
EPS, quarterly-0.427-0.252-0.354-0.214-0.309-0.287-0.294-0.183-0.173
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Sales, annual00000000
Period2019202020212022202320242025TTM
Sales, quarterly000000000
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Shares, annual18.7418.7418.71319.40329.74129.9227.41337.89
Period2019202020212022202320242025MRQ
Shares, quarterly29.86929.9230.14227.37627.37127.41335.98636.30937.89
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY
Total Revenue0.000.000.000.000.000.000.000.00
Cost of Goods Sold Incl. D&A0.000.000.000.000.080.000.000.00
Gross Profit0.000.000.000.00-0.080.000.000.00
Selling, General and Administrative Excl. Other37.4438.1154.5569.6442.1921.577.285.18
Research and Development25.3624.7740.4954.8729.5116.916.024.89
Other Operating Expense0.000.000.000.000.000.000.000.00
Operating Income-37.44-38.11-54.55-69.64-42.26-21.57-7.28-5.18
Interest Expense0.000.000.000.000.000.000.000.00
Unusual Expense0.000.002.230.000.000.000.000.00
Net Income Before Taxes-34.88-35.17-51.32-64.73-40.96-21.54-13.60-5.63
Income Taxes0.000.000.000.000.000.000.000.00
Consolidated Net Income-34.88-35.17-51.32-64.73-40.96-21.54-13.60-5.63
Net Income From Continuing Operations-34.88-35.17-51.32-64.73-40.96-21.54-13.60-5.63
Net Income-34.88-35.17-51.32-64.73-42.78-28.06-14.58-5.73
EPS (Recurring)-0.76-1.16-1.67-2.74-2.20-1.50-0.78-0.31
EPS (Basic, Before Extraordinaries)-0.94-1.16-1.72-2.74-2.20-1.50-0.78-0.31
EPS (Diluted)-0.94-1.16-1.72-2.74-2.20-1.50-0.78-0.31
EBITDA-37.44-38.11-54.55-69.64-42.19-21.57-7.28-5.18
Non-Operating Income (Expense)2.562.945.474.901.310.03-6.32-0.46
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense4.806.258.348.414.390.970.04-
Shares Outstanding37.8927.4129.9229.7419.4018.7118.7418.74
Market Capitalization163.40163.4041.23609.40184.91184.91--

Income statement, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q22025Q12024Q4
Total Revenue0.000.000.000.000.000.000.000.00
Cost of Goods Sold Incl. D&A0.000.000.000.000.000.000.000.00
Gross Profit0.000.000.000.000.000.000.000.00
Selling, General and Administrative Excl. Other8.678.9010.559.3210.047.2211.548.61
Research and Development5.726.026.746.887.003.207.695.40
Other Operating Expense0.000.000.000.000.000.000.000.00
Operating Income-8.67-8.90-10.55-9.32-10.04-7.22-11.54-8.61
Interest Expense0.000.000.000.000.000.000.000.00
Unusual Expense0.000.000.000.000.000.000.00-0.01
Net Income Before Taxes-7.96-8.19-10.03-8.71-9.35-6.46-10.65-7.52
Income Taxes0.000.000.000.000.000.000.000.00
Consolidated Net Income-7.96-8.19-10.03-8.71-9.35-6.46-10.65-7.52
Net Income From Continuing Operations-7.96-8.19-10.03-8.71-9.35-6.46-10.65-7.52
Net Income-7.96-8.19-10.03-8.71-9.35-6.46-10.65-7.52
EPS (Recurring)-0.17-0.18-0.29-0.29-0.31-0.21-0.35-0.25
EPS (Basic, Before Extraordinaries)-0.17-0.18-0.29-0.29-0.31-0.21-0.35-0.25
EPS (Diluted)-0.17-0.18-0.29-0.29-0.31-0.21-0.35-0.25
EBITDA-8.67-8.90-10.55-9.32-10.04-7.22-11.54-8.61
Non-Operating Income (Expense)0.710.720.520.610.690.750.891.08
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense0.970.971.461.400.802.002.051.78
Shares Outstanding37.8936.3135.9927.4127.3727.3830.1429.92
Market Capitalization163.40174.32122.9231.2434.7031.9940.9341.23

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY2022FY2021FY2020FY2019FY
Cash & Short Term Investments58.0083.62107.3096.0658.554.075.60
Short Term Receivables0.900.301.400.000.000.000.00
Inventories0.000.000.000.000.000.000.00
Other Current Assets1.042.341.812.561.550.160.10
Total Current Assets59.9486.26110.5198.6260.114.235.70
Net Property, Plant & Equipment0.000.000.000.000.000.000.00
Total Investments and Advances2.015.0227.193.223.490.000.00
Intangible Assets0.00---0.000.000.00
Other Assets0.000.801.040.721.720.000.00
Total Assets61.9592.09138.74102.5665.324.235.70
Short Term Debt Incl. Current Port. of LT Debt0.000.000.000.050.000.000.00
Accounts Payable3.023.320.000.000.000.000.00
Other Current Liabilities5.706.9214.047.133.401.460.16
Total Current Liabilities8.7210.2414.047.193.401.460.16
Long Term Debt0.000.000.000.000.000.000.00
Provision for Risks Charges0.000.000.000.000.000.000.00
Other Liabilities0.170.000.000.000.010.020.73
Total Liabilities8.8910.2414.047.193.411.480.89
Non-Equity Reserves0.000.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.00109.3223.0710.61
Common Equity53.0681.85124.7095.37-47.41-20.32-5.80
Total Shareholders Equity53.0681.85124.7095.3761.912.754.81
Accumulated Minority Interest0.000.000.000.000.000.000.00
Total Equity53.0681.85124.7095.3761.912.754.81
Total Liabilities & Stockholders Equity61.9592.09138.74102.5665.324.235.70
Book Value Per Share1.942.744.194.92-2.53-1.08-0.31
Tangible Book Value Per Share1.942.744.194.92-2.53-1.08-0.31
Full-Time Employees212241352223-
Price to Book Ratio2.170.474.391.751.75--
Return on Assets-45.67-44.47-53.65-48.79-61.95-273.87-
Return on Equity-52.14-49.69-58.83-52.08-66.64-359.68-
Return on Invested Capital-66.29-62.70-51.91-42.94-34.80-494.47-117.08
Quick Ratio6.878.437.8713.7217.702.9035.85
Current Ratio6.878.437.8713.7217.702.9035.85

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY
Net Income-34.88-35.17-51.32-64.73-40.96-21.54-13.60-5.63
Depreciation----0.08---
Other Funds (Non Cash)4.315.185.065.613.701.037.013.16
Funds from Operations-30.57-30.00-46.26-59.12-37.18-20.52-6.59-2.48
Extraordinary Item0.000.000.000.000.000.000.000.00
Changes in Working Capital0.160.16-3.005.833.720.031.22-0.01
Cash from Operating Activities-30.41-29.83-49.26-53.29-33.46-20.48-5.36-2.49
Capital Expenditures0.000.000.000.000.000.000.000.00
Net Assets From Acquisitions0.000.000.000.000.000.000.000.00
Sale of Fixed Assets and Businesses0.000.000.000.000.000.000.000.00
Purchase or Sale of Investments-12.6428.3154.59-43.28-21.77-50.020.000.00
Purchase of Investments-58.13-46.19-46.75-132.18-93.84-77.270.000.00
Sale Or Maturity of Investments45.4974.50101.3488.9072.0627.250.000.00
Other Uses0.000.000.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.000.000.00
Cash from Investing Activities-12.6428.3154.59-43.28-21.77-50.020.000.00
Cash Dividends Paid0.000.000.000.000.000.000.000.00
Change in Capital Stock45.250.110.3784.9970.3678.533.848.08
Repurchase of Common Pref Stock0.000.000.000.00-0.010.000.000.00
Sale of Common Pref Stock45.250.110.3784.9970.3778.533.848.08
Proceedsfrom Stock Options45.010.090.1584.8970.3778.523.778.08
Issuance or Reduction of Debt, Net0.000.000.000.000.000.000.000.00
Change in Long Term Debt0.000.000.000.000.000.000.000.00
Issuance of Long Term Debt0.000.000.000.000.000.000.000.00
Reduction of Long Term Debt0.000.000.000.000.000.000.000.00
Net Financing Active Other Cash Flow0.000.000.000.000.000.000.000.00
Other Financing Activities Uses0.000.000.000.000.000.000.000.00
Cash from Financing Activities45.250.110.3784.9970.3678.533.848.08
Net Change in Cash2.20-1.415.70-11.5715.128.03-1.535.60
Free Cash Flow-30.41-29.83-49.26-53.29-33.46-20.48-5.36-2.49
Preferred Dividends (Cash Flow)-0.000.000.00----
Deferred Taxes & Investment Tax Credit-0.000.000.000.000.000.000.00

Balance sheet, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Cash & Short Term Investments64.4078.3985.2958.0061.9262.92
Short Term Receivables0.400.300.300.900.402.70
Inventories0.000.000.000.000.000.00
Other Current Assets0.961.301.901.041.701.91
Total Current Assets65.7679.9987.4959.9464.0267.52
Net Property, Plant & Equipment0.000.000.000.000.000.00
Total Investments and Advances15.801.470.002.013.228.30
Intangible Assets--0.000.000.000.00
Other Assets0.390.220.000.000.000.00
Total Assets81.9581.6887.4961.9567.2375.83
Short Term Debt Incl. Current Port. of LT Debt0.000.000.000.000.000.00
Accounts Payable1.661.972.623.022.232.11
Other Current Liabilities4.613.622.955.704.634.87
Total Current Liabilities6.285.585.568.726.866.98
Long Term Debt0.000.000.000.000.000.00
Provision for Risks Charges0.000.000.000.000.000.00
Other Liabilities0.170.170.170.170.000.00
Total Liabilities6.455.755.738.896.866.98
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.00
Common Equity75.5175.9281.7653.0660.3868.84
Total Shareholders Equity75.5175.9281.7653.0660.3868.84
Accumulated Minority Interest0.000.000.000.000.000.00
Total Equity75.5175.9281.7653.0660.3868.84
Total Liabilities & Stockholders Equity81.9581.6887.4961.9567.2375.83
Book Value Per Share1.992.092.271.942.212.51
Tangible Book Value Per Share1.992.092.271.942.212.51
Full-Time Employees---21--
Price to Book Ratio2.172.131.770.520.510.44
Return on Assets-46.76-46.06-40.93-45.67-41.21-40.56
Return on Equity-51.34-50.12-44.56-52.14-45.91-44.71
Return on Invested Capital-10.54-10.78-12.27-16.42-15.49-9.39
Quick Ratio10.4814.3215.736.879.339.67
Current Ratio10.4814.3215.736.879.339.67

Cash flow, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Net Income-7.96-8.19-10.03-8.71-9.35-6.46
Other Funds (Non Cash)0.770.881.381.280.591.70
Funds from Operations-7.19-7.31-8.65-7.43-8.76-4.76
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital1.080.31-3.422.192.39-2.84
Cash from Operating Activities-6.10-7.00-12.07-5.24-6.38-7.60
Capital Expenditures0.000.000.000.000.000.00
Net Assets From Acquisitions0.000.000.000.000.000.00
Sale of Fixed Assets and Businesses0.000.000.000.000.000.00
Purchase or Sale of Investments-24.44-3.668.297.176.115.83
Purchase of Investments-33.44-13.66-2.70-8.33-3.89-11.67
Sale Or Maturity of Investments9.0010.0010.9915.5010.0017.50
Other Uses0.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.00
Cash from Investing Activities-24.44-3.668.297.176.115.83
Cash Dividends Paid0.000.000.000.000.000.00
Preferred Dividends (Cash Flow)0.000.000.000.000.000.00
Change in Capital Stock6.431.4937.330.000.050.00
Repurchase of Common Pref Stock0.000.000.000.000.000.00
Sale of Common Pref Stock6.431.4937.330.000.050.00
Proceedsfrom Stock Options6.271.4437.300.000.050.00
Issuance or Reduction of Debt, Net0.000.000.000.000.000.00
Change in Long Term Debt0.000.000.000.000.000.00
Issuance of Long Term Debt0.000.000.000.000.000.00
Reduction of Long Term Debt0.000.000.000.000.000.00
Net Financing Active Other Cash Flow0.000.000.000.000.000.00
Other Financing Activities Uses0.000.000.000.000.000.00
Cash from Financing Activities6.431.4937.330.000.050.00
Net Change in Cash-24.11-9.1733.551.94-0.22-1.76
Free Cash Flow-6.10-7.00-12.07-5.24-6.38-7.60

Revenue breakdown

Revenue split-

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-308.63%2.4M28.3M264.95K
2026-10-1510.21%2.9M28.3M245.73K
2026-09-308.81%2.5M28.3M222.15K
2026-09-158.47%2.4M28.3M287.47K
2026-08-318.97%2.5M28.0M283.67K
2026-08-147.95%2.2M28.0M289.20K
2026-07-319.06%2.4M26.2M289.97K
2026-07-159.28%2.4M26.2M310.60K
2026-06-307.29%1.9M26.4M335.21K
2026-06-154.95%1.3M26.4M296.53K
2026-05-294.58%1.2M26.4M1.46M
2026-05-153.17%0.8M26.4M1.44M
2026-04-303.33%0.9M26.5M1.43M
2026-04-153.07%0.6M20.7M1.42M
2026-03-312.78%0.6M20.3M1.38M
2026-03-133.50%0.7M20.3M1.31M
2026-02-270.38%0.1M15.5M89.08K
2026-02-130.34%0.1M15.5M80.42K
2026-01-300.34%0.1M15.3M87.64K
2026-01-150.33%0.1M15.3M89.33K

Option chain

expiry 2026-11-20
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
call1.002.505.802.720.0002.000.000.979-0.0130.000
call2.000.004.900.000.0000.000.000.959-0.0120.001
call3.000.104.900.000.0000.000.000.927-0.0110.001
call4.000.004.101.2522.1132.000.000.967-0.0670.001
call5.000.150.300.201.79689.002420.395-0.0270.003
call6.000.004.900.002.6820.000.000.309-0.0370.002
call7.000.004.900.003.5220.000.000.269-0.0430.002
call8.000.004.900.003.8300.000.000.248-0.0480.002
call9.000.004.900.004.2500.000.000.233-0.0510.002
call10.000.000.750.004.6090.000.000.222-0.0540.002
call11.000.004.900.004.9220.000.000.213-0.0560.002
put1.000.003.600.006.2360.000.00-0.021-0.0120.000
put2.000.003.600.003.5130.000.00-0.041-0.0120.001
put3.000.000.050.050.00050.000.000.0000.0000.000
put4.000.003.700.0023.2800.000.00-0.033-0.0670.001
put5.000.004.004.9016.0820.000.00-0.605-0.0270.003
put6.000.004.900.0016.0220.000.00-0.691-0.0370.002
put7.000.104.900.0011.2640.000.00-0.730-0.0420.002
put8.001.356.000.0012.2180.000.00-0.752-0.0470.002
put9.002.107.000.0012.6550.000.00-0.767-0.0500.002
put10.003.108.000.0013.0290.000.00-0.778-0.0530.002
put11.004.309.000.0013.3520.000.00-0.787-0.0550.002

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-11-0910-QQuarterly report pursuant to Section 13 or 15(d)2026-09-30SEC
2026-11-098-KCurrent report2026-11-09SEC
2026-11-064Statement of changes in beneficial ownership of securities2026-11-05SEC
2026-10-134Statement of changes in beneficial ownership of securities2026-10-12SEC
2026-10-134Statement of changes in beneficial ownership of securities2026-10-12SEC
2026-10-134Statement of changes in beneficial ownership of securities2026-10-12SEC
2026-09-164Statement of changes in beneficial ownership of securities2026-09-15SEC
2026-09-14S-8Initial registration statement for securities to be offered to employees pursuant to employee benefit plansSEC
2026-09-114Statement of changes in beneficial ownership of securities2026-09-09SEC
2026-09-084Statement of changes in beneficial ownership of securities2026-09-03SEC
2026-09-044Statement of changes in beneficial ownership of securities2026-09-01SEC
2026-09-024Statement of changes in beneficial ownership of securities2026-09-01SEC
2026-08-273Initial statement of beneficial ownership of securities2026-08-24SEC
2026-08-194Statement of changes in beneficial ownership of securities2026-08-17SEC
2026-08-17144Filing for proposed sale of securities under Rule 144.SEC
2026-08-144Statement of changes in beneficial ownership of securities2026-08-14SEC
2026-08-1110-QQuarterly report pursuant to Section 13 or 15(d)2026-06-30SEC
2026-08-118-KCurrent report2026-08-11SEC
2026-07-104Statement of changes in beneficial ownership of securities2026-07-10SEC
2026-07-104Statement of changes in beneficial ownership of securities2026-07-10SEC
2026-07-104Statement of changes in beneficial ownership of securities2026-07-10SEC
2026-07-104Statement of changes in beneficial ownership of securities2026-07-08SEC
2026-06-098-KCurrent report2026-06-03SEC
2026-06-048-KCurrent report2026-06-04SEC
2026-06-024Statement of changes in beneficial ownership of securities2026-05-29SEC
2026-05-15SCHEDULE 13G/ASEC
2026-05-1110-QQuarterly report pursuant to Section 13 or 15(d)2026-03-31SEC
2026-05-118-KCurrent report2026-05-11SEC
2026-04-22ARSAnnual report to security holders. 2025-12-31SEC
2026-04-22DEFA14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934SEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-110011.93K1
2026-100000
2026-0911.60K1105.50K4
2026-0800212.70K1
2026-070024.80K1
2026-060000
2026-05001.17K1
2026-040000
2026-03003471
2026-020000
2026-010049.68K8
2025-120000
2025-11004.09K2

Institutional holders

Manager% owned
Vivo Capital, LLC8.76%
Commodore Capital LP8.15%
MILLENNIUM MANAGEMENT LLC6.44%
BlackRock, Inc.4.62%
Spruce Street Capital LP4.61%
Almitas Capital LLC4.08%
VANGUARD CAPITAL MANAGEMENT LLC3.44%
ADAGE CAPITAL PARTNERS GP, L.L.C.2.78%
CITADEL ADVISORS LLC2.64%
Boxer Capital Management, LLC2.08%

Funds

Fund% owned
VANGUARD TOTAL STOCK MARKET INDEX FUND2.37%
iShares Russell 2000 ETF1.67%
VANGUARD EXTENDED MARKET INDEX FUND1.00%
Fidelity Small Cap Index Fund0.80%
iShares Russell 2000 Value ETF0.54%
VANGUARD RUSSELL 2000 INDEX FUND0.40%
Fidelity Extended Market Index Fund0.25%
iShares Micro-Cap ETF0.25%
Schwab Small-Cap Index Fund0.18%
Ultra-Small Company Market Fund0.16%

OakChart. ANTX. Cached 15 minutes.